Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-009374
Filing Date
2025-04-01
Accepted
2025-04-01 16:32:21
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 form4-04012025_080418.html 4  
1 form4-04012025_080418.xml 4 4698
  Complete submission text file 0001415889-25-009374.txt   6123
Mailing Address C/O ICAD INC 98 SPIT BROOK ROAD SUITE 100 NASHUA NH 03062
Business Address
Subramaniam Somu (Reporting) CIK: 0001508910 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 25800260

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)